Patents by Inventor Rafal Andrzej Derlacz

Rafal Andrzej Derlacz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190225694
    Abstract: The present invention is directed to a cell culture obtainable from CHO DG44 cells which are capable of being cultured under serum-free or protein-free culture conditions, and which express a biosimilar antibody for the monoclonal antibody natalizumab. The present invention is further directed to a cell of said cell culture, a method for producing said biosimilar antibody, and the use of said cell in said method.
    Type: Application
    Filed: June 27, 2017
    Publication date: July 25, 2019
    Inventors: Piotr Marcin Zien, Matthew Christopher Cheeks, Tomasz Sitar, Kornelia Bogumila Wisniewska, Rafal Andrzej Derlacz